Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 8/7/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Sandra M. Gaston

Wrong Dr. Sandra M. Gaston?

Director of Urological Research

Phone: (617) ***-****  HQ Phone
Email: s***@***.org
New England Baptist Hospital
125 Parker Hill Avenue
Boston , Massachusetts 02120
United States

Company Description: New England Baptist Hospital (NEBH) has been dedicated to exceptional patient care since its inception in 1883. We are an adult Medical/Surgical Hospital with...   more

Employment History


  • PhD
    Harvard Medical School
11 Total References
Web References
MDxHealth - Press Releases & Events, 16 May 2011 [cached]
The presentation of this important new prostate cancer data at the American Urology Association (AUA) Annual Meeting in Washington DC by Dr. Sandra Gaston of Beth Israel Deaconess Medical Center resulted from a collaborative effort between MDxHealth, Beth Israel Deaconess, Harvard Medical School, the New England Baptist Hospital, and the NCI's Early Detection research Network (EDRN).
Dr. Gaston added: "One striking feature of our results is the extent of gene methylation abnormalities observed in prostate tissues from many patients with only 1 of 12 biopsy cores positive for cancer, compared to men with normal biopsies.
Genomic Sample Prep and Biospecimen Science Conference 2015, 25 June 2013 [cached]
Sandra M. Gaston, Ph.D., Director, Molecular Biomarkers Research Laboratory,Pathology and Laboratory Medicine, Tufts Medical Center Assistant Professor of Pathology, Tufts University School of Medicine
"These data demonstrate that ConfirmMDx ..., 10 Oct 2014 [cached]
"These data demonstrate that ConfirmMDx for Prostate Cancer not only provides important diagnostic information to help guide the decision on repeat biopsy, but that the genes may also deliver significant prognostic value, potentially determining whether a man has an aggressive or non-aggressive form of prostate cancer," noted Sandra M. Gaston PhD, Director of Urological Research at New England Baptist Hospital and Director of the Molecular Biomarkers Research Laboratory in the Department of Pathology and Laboratory Medicine at Tufts Medical Center in Boston Massachusetts.
Sample Prep Conference, 21 Aug 2012 [cached]
Sandra M. Gaston, Ph.D., Director, Molecular Biomarkers Research Laboratory, Department of Pathology and Laboratory Medicine, Tufts Medical Center Assistant Professor of Pathology, Tufts University School of Medicine
Dr. Susan Love Research Foundation | Ending Breast Cancer - 2003 Grantees, 19 June 2005 [cached]
Researcher: Sandra Gaston, MD, Instructor in Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. Project: Matrix Metalloproteinase 9 Expression and Secretion in Healthy Mammary Ducts: Risk Factor for Breast Cancer?
Dr. Gaston and her team hypothesize that men with a high set point for constitutive prostatic MMP-9 expression are predisposed to biologically aggressive prostate cancer.
Other People with the name "Gaston":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.